PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns. Have an internal positioning decision? The private Sprint uses a separate evidence boundary.

See the private Research Sprint →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION <1h ago7943 SIGNALS8 FEEDS580 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
1221 Opportunity dossier O-1725 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1222 Opportunity dossier O-1699 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1223 Opportunity dossier O-1697 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1224 Opportunity dossier O-1677 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1225 Opportunity dossier O-1671 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1226 Opportunity dossier O-1637 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1227 Opportunity dossier O-1633 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1228 Opportunity dossier O-1600 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1229 Opportunity dossier O-1576 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1230 Opportunity dossier O-1545 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1231 Opportunity dossier O-1538 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1232 Opportunity dossier O-1536 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1233 Opportunity dossier O-1511 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1234 Opportunity dossier O-1497 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1235 Opportunity dossier O-1487 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1236 Opportunity dossier O-1479 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1237 Opportunity dossier O-1454 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1238 Opportunity dossier O-1447 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1239 Opportunity dossier O-1436 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1240 Opportunity dossier O-1428 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.